Design Therapeutics (DSGN) Interest & Investment Income (2024 - 2026)

Design Therapeutics has disclosed Interest & Investment Income across 3 years of filings, most recently posting $2.1 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $2.1 million, down 23.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.0 million (down 25.9% YoY), and the FY2025 annual result was $9.7 million, down 24.38% from the prior year.
• Interest & Investment Income came in at $2.1 million for Q1 2026 at Design Therapeutics, down from $2.2 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $3.3 million in Q1 2024 to a low of $2.1 million in Q1 2026.
• The 3-year median for Interest & Investment Income is $2.7 million (2025), against an average of $2.7 million.
• Peak annual rise in Interest & Investment Income reached 17.97% in 2025, while the deepest fall reached 28.62% in 2025.
• Design Therapeutics' Interest & Investment Income stood at $3.0 million in 2024, then fell by 28.62% to $2.2 million in 2025, then slipped by 4.7% to $2.1 million in 2026.
• The last three Interest & Investment Income figures came in at $2.1 million (Q1 2026), $2.2 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.